Stay updated on Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.

Latest updates to the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, updating the page's version metadata.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThis update corresponds to the study’s **results being posted (2026-04-24)** and revises/defines key **outcome measure details**—notably the timing and definitions of endpoints such as **time to hospital readmission or death (all-cause and respiratory-cause)**, **treatment failure**, and counts of hospital readmissions and exacerbations over the **48-week** period. It also updates the specification of several measured patient outcomes (e.g., questionnaire-based health status scales such as eMRC/WEMWBS/SPPB/LCADL, oxygen/inflammatory marker outcomes, and continuous measures including temperature and heart rate across the follow-up window).SummaryDifference5%

- Check48 days agoChange DetectedRevision updated from v3.0.0 to v3.5.2.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 in the Study Plan.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page. This change affects only the revision metadata, not the study details or user actions.SummaryDifference0.1%

- Check112 days agoChange DetectedRevision label on the page updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.